The Vasculitis Foundation and the Mayo Clinic Arizona Present:
The 2019 Vasculitis Patient Patient Conference – Phoenix, Arizona
The conference is open to patients with vasculitis, their families, friends, and health care providers interested in learning more about vasculitis.
Mayo Clinic Education Center – Waugh Auditorium
5777 East Mayo Boulevard, Phoenix, Arizona 85054
Saturday, March 9, 2019
Registration fees: $25.00 for VF members; $40 for non-members
Click here to register.
Registration deadline: March 4, 2019
A limited # of scholarships are available. Please contact the VF office for information.
8:30 a.m. – 9:15 a.m.
Registration and Light Continental Breakfast
9:15 a.m. – 9:30 a.m.
Welcome and Introductions
Rodrigo Cartin-Ceba, MD, Pulmonary and Critical Care Medicine, Mayo Clinic Arizona
9:30 a.m. – 10:00 a.m.
Large Vessel Vasculitis
Kenneth J. Warrington, MD
Chair, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota
10:00 a.m. – 10:30 a.m.
Lung Involvement in Vasculitis
Rodrigo Cartin-Ceba, MD
10:30 a.m. – 10:45 a.m.
10:45 a.m. – 11:15 a.m.
Advances in Treatment of ANCA-associated Vasculitis
Ulrich Specks, MD, Chair, Division of Pulmonary and Critical Care, Mayo Clinic, Rochester, Minnesota
11:15 a.m. – 11:45 a.m.
Upper Airway Involvement in Vasculitis
David G. Lott, MD
Division of Otolaryngology, Mayo Clinic Arizona
11:45 a.m. – 12:00 p.m.
Vasculitis Patient-Powered Research Network (VPPRN)
Kalen Young, V-PPRN Network Manager, Vasculitis Foundation
12:00 p.m. – 1:00 p.m.
Lunch/Patient Experience Stories
VF Board of Director
1:00 p.m. – 1:30 p.m.
Kidney Involvement in Vasculitis
Alicia Rodriguez-Pla, MD, PhD
Arthritis Center, University of Arizona, Tucson, Arizona
1:30 p.m. – 2:00 p.m.
New Biologicals for Asthma Management
Matthew A. Rank, MD, Chair, Division of Allergy and Immunology, Mayo Clinic Arizona
2:00 p.m. – 2:30 p.m.
Managing Long-term Corticosteroid Therapy
2:30 p.m. – 2:45 p.m.
Wrap-up and Thank You
Dr. Cartin-Ceba and Joyce Kullman, Executive Director, Vasculitis Foundation
2:45 p.m. – 3:30 p.m.
Conference support provided by an educational grant from Celgene and Genentech, a Member of the Roche Group.